Fistulotomy With Marsupialization Versus Fistulectomy With Wound Sutures in Simple Anal Fistula
NCT ID: NCT04215718
Last Updated: 2020-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
92 participants
INTERVENTIONAL
2017-04-01
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fistulotomy With or Without Marsupialization for Treatment of Simple Anal Fistula
NCT03595839
Rerouting Seton Versus LIFT for Complex Anal Fistula
NCT04616911
Treatment of Anal Fistulas Advancement Flap
NCT01042821
Ligation of Intersphincteric Track (LIFT) Versus Fistulectomy in Trans-sphincteric Anal Ffistula.
NCT04351074
Fistulotomy Versus Fistulotomy With Marsupialization
NCT05660876
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomization was done using computer generated cards, the trial was approved by institutional review board (IRB) and the ethical committee of our hospitals, all study participants signed an informed written consent.
The condition of this trial is simple anal fistula defined as non-branched fistula confined to the lower third of the anal sphincter diagnosed by anorectal examination or MRI if needed, the primary outcomes are; the time taken for complete healing, fistula recurrence and anal incontinence diagnosed by Vaizey score patient's questionnaire. The secondary outcomes are local wound complications and postoperative pain calculated by visual analogue score (VAS). Study participants number was calculated through the IRB depending on the incidence of simple anal fistula in our locality.
inclusion criteria
• patients above 18 years diagnosed with simple non recurrent anal fistula.
exclusion criteria:
* Anorectal malignancy.
* Specific disease (Crohn's disease).
* ASA class III, VI and any contraindication for surgery
* Immunocompromised patients and those on steroid therapy or cytotoxic drugs.
* Perianal collection. participants of this study were subjected to proper history taking and full clinical examination for diagnosis of the condition, detection of any associated disease and \\ or exclusion factor. MRI was ordered if there is any doubt about diagnosis, preoperative investigations were ordered as per usual.
The procedure in both groups was carried out by the study surgeons, under general anesthesia in lithotomy position, anorectal examination was done to identify the internal and external openings, course of fistulous track and any side tracks if present. When the internal opening couldn't be identified the operator used methylene blue dye injection through the external opening. In fistulotomy group and after probing of the track it was let open by diathermy, its floor was curetted and the wound edges marsupialized by polygalactin (Vicryl) sutures 3\\0.
In fistulectomy group and after probing, the fistulous track was excised by diathermy together with its internal and external openings, after hemostasis the wound was closed by polygalactin (Vicryl) sutures 3\\0.
In both groups the wound was dressed with non-adhesive dressing, Nonsteroidal analgesics were given as per need and participants were discharged after 24 hours if there is no contraindication to do so.
After discharge study participants were encouraged for self-cleaning by antiseptic baths.
Follow up was carried out in the outpatient clinics by the study surgeons, the clinic visits were planed every week for 12 weeks then monthly for another three months, in each visit the investigator recorded the state of wound healing, anal continence, postoperative pain, any local wound complications, and any recurrence after complete healing in the follow up time.
Preoperative data, demographic data, operative time, intraoperative complications and follow up data were collected and properly analyzed using paired t test and Z tests in SPSS 22 program package.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fistulotomy group
46 patients with simple anal fistula underwent fistulotomy and marsupialization of wound edges
fistulotomy and marsupialization
the anal fistula was laid open and the the wound edges was marsupialized using vicryle 3\\0 sutures
fistulectomy group
46 patients with simple anal fistula underwent fistulectomy and closure of the wound
fistulectomy and wound closure
anal fistula was excised with both openings and the wound was closed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fistulotomy and marsupialization
the anal fistula was laid open and the the wound edges was marsupialized using vicryle 3\\0 sutures
fistulectomy and wound closure
anal fistula was excised with both openings and the wound was closed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Specific disease (Crohn's disease).
* ASA class III, VI and any contraindication for surgery
* Immunocompromized patients and those on steroid therapy or cytotoxic drugs.
* Perianal collection.
18 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hazem Nour Abdellatif
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hazem nour, MD
Role: PRINCIPAL_INVESTIGATOR
zag university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zagazig Faculty of Medicine
Zagazig, Sharqya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
anal fistula wound
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.